BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35649719)

  • 1. Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies.
    Senev A; Lerut E; Coemans M; Callemeyn J; Copley HC; Claas F; Koshy P; Kosmoliaptsis V; Kuypers D; Sprangers B; Van Craenenbroeck A; Van Loon E; Van Sandt V; Emonds MP; Naesens M
    Clin J Am Soc Nephrol; 2022 Aug; 17(8):1204-1215. PubMed ID: 35649719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.
    Callemeyn J; Lerut E; de Loor H; Arijs I; Thaunat O; Koenig A; Meas-Yedid V; Olivo-Marin JC; Halloran P; Chang J; Thorrez L; Kuypers D; Sprangers B; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2168-2183. PubMed ID: 32641395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
    Senev A; Van Loon E; Lerut E; Callemeyn J; Coemans M; Van Sandt V; Kuypers D; Emonds MP; Naesens M
    Kidney Int; 2021 Aug; 100(2):401-414. PubMed ID: 33675843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Histological Picture of Indication Biopsies in the First 2 Weeks after Kidney Transplantation.
    Van Loon E; Lerut E; Senev A; Coemans M; Pirenne J; Monbaliu D; Jochmans I; Sainz Barriga M; De Vusser K; Van Craenenbroeck AH; Sprangers B; Emonds MP; Kuypers D; Naesens M
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1484-1493. PubMed ID: 32778537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-specific antibodies, glomerulitis, and human leukocyte antigen B eplet mismatch are risk factors for peritubular capillary C4d deposition in renal allografts.
    Zheng J; Guo H; Gong HL; Lan P; Ding CG; Li Y; Ding XM; Xue WJ
    Chin Med J (Engl); 2021 Oct; 134(23):2874-2881. PubMed ID: 34711716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
    Reindl-Schwaighofer R; Heinzel A; Kainz A; van Setten J; Jelencsics K; Hu K; Loza BL; Kammer M; Heinze G; Hruba P; Koňaříková A; Viklicky O; Boehmig GA; Eskandary F; Fischer G; Claas F; Tan JC; Albert TJ; Patel J; Keating B; Oberbauer R;
    Lancet; 2019 Mar; 393(10174):910-917. PubMed ID: 30773281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated rejection owing to donor-specific HLA-DQA1 antibodies after renal transplantation: A case report.
    Liu W; Kang ZY; Wang ZL; Li DH
    Transpl Immunol; 2022 Aug; 73():101607. PubMed ID: 35477043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.
    Lan JH; Kadatz M; Chang DT; Gill J; Gebel HM; Gill JS
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):275-283. PubMed ID: 33495290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation.
    Senev A; Ray B; Lerut E; Hariharan J; Heylen C; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Front Immunol; 2022; 13():809059. PubMed ID: 35250981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients.
    Fichtner A; Süsal C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Dragun D; Tönshoff B
    Pediatr Nephrol; 2021 Aug; 36(8):2473-2484. PubMed ID: 33759004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
    Shimizu T; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.